Combined use of recombinant activated factor VII and ECMO in severe postoperative bleeding after cardiac surgery in a newborn: death due to ventricular dysfunction.
Olbrich, P
Combined use of recombinant activated factor VII and ECMO in severe postoperative bleeding after cardiac surgery in a newborn: death due to ventricular dysfunction. [electronic resource] - Klinische Padiatrie Apr 2012 - 193-4 p. digital
Publication Type: Case Reports; Journal Article
1439-3824
10.1055/s-0032-1308984 doi
Acute Kidney Injury--etiology
Cardiopulmonary Bypass
Cause of Death
Chest Tubes
Combined Modality Therapy
Extracorporeal Membrane Oxygenation
Factor VIIa--therapeutic use
Fatal Outcome
Heart Ventricles--pathology
Humans
Infant, Newborn
Ischemia--pathology
Multiple Organ Failure--etiology
Necrosis
Off-Label Use
Postoperative Complications--etiology
Postoperative Hemorrhage--pathology
Recombinant Proteins--therapeutic use
Transposition of Great Vessels--pathology
Ventricular Dysfunction, Left--etiology
Combined use of recombinant activated factor VII and ECMO in severe postoperative bleeding after cardiac surgery in a newborn: death due to ventricular dysfunction. [electronic resource] - Klinische Padiatrie Apr 2012 - 193-4 p. digital
Publication Type: Case Reports; Journal Article
1439-3824
10.1055/s-0032-1308984 doi
Acute Kidney Injury--etiology
Cardiopulmonary Bypass
Cause of Death
Chest Tubes
Combined Modality Therapy
Extracorporeal Membrane Oxygenation
Factor VIIa--therapeutic use
Fatal Outcome
Heart Ventricles--pathology
Humans
Infant, Newborn
Ischemia--pathology
Multiple Organ Failure--etiology
Necrosis
Off-Label Use
Postoperative Complications--etiology
Postoperative Hemorrhage--pathology
Recombinant Proteins--therapeutic use
Transposition of Great Vessels--pathology
Ventricular Dysfunction, Left--etiology